MAPT and Alzheimer disease: It will provide valuable insights into the underlying mechanisms if measuring AD biomarkers such as Aβ, phosphorylated tau (p-tau) and total tau (t-tau) in cerebrospinal fluid (CSF) and brain atrophy in future clinical research.